Financials PW Medtech Group Limited

Equities

1358

KYG7306W1087

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:22 2024-04-29 am EDT 5-day change 1st Jan Change
0.96 HKD +1.05% Intraday chart for PW Medtech Group Limited +1.05% +17.07%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 1,855 1,405 1,977 2,840 1,279 871.1
Enterprise Value (EV) 1 1,491 1,874 2,434 1,168 -1,131 -512.2
P/E ratio 15.3 x 0.84 x 24.1 x 4.49 x 1.73 x 8.22 x
Yield - - - - - -
Capitalization / Revenue 6.47 x 4.52 x 5.46 x 11.5 x 4.71 x 1.62 x
EV / Revenue 5.2 x 6.03 x 6.72 x 4.72 x -4.17 x -0.95 x
EV / EBITDA 23.1 x 22.9 x 35.1 x 91.9 x -14 x -2.92 x
EV / FCF -1.4 x 1.51 x 71.1 x -0.55 x -0.51 x 2.17 x
FCF Yield -71.3% 66.2% 1.41% -181% -197% 46.2%
Price to Book 0.67 x 0.31 x 0.43 x 0.56 x 0.34 x 0.22 x
Nbr of stocks (in thousands) 1,568,632 1,569,246 1,569,246 1,569,246 1,569,246 1,565,632
Reference price 2 1.183 0.8956 1.260 1.810 0.8148 0.5564
Announcement Date 4/27/18 4/24/19 4/28/20 4/23/21 4/21/22 4/26/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 286.9 310.8 362.2 247.4 271.4 536.8
EBITDA 1 64.42 81.84 69.27 12.71 80.86 175.5
EBIT 1 44.7 61.81 40.86 -14.92 49.95 98.17
Operating Margin 15.58% 19.89% 11.28% -6.03% 18.4% 18.29%
Earnings before Tax (EBT) 1 45.08 126.6 85.81 626.6 737.5 157.7
Net income 1 122.1 1,666 81.98 631.8 739.1 106
Net margin 42.55% 535.89% 22.64% 255.43% 272.34% 19.75%
EPS 2 0.0774 1.062 0.0522 0.4026 0.4710 0.0677
Free Cash Flow 1 -1,063 1,240 34.23 -2,117 2,230 -236.5
FCF margin -370.34% 398.93% 9.45% -855.79% 821.81% -44.06%
FCF Conversion (EBITDA) - 1,514.98% 49.42% - 2,758.32% -
FCF Conversion (Net income) - 74.44% 41.76% - 301.76% -
Dividend per Share - - - - - -
Announcement Date 4/27/18 4/24/19 4/28/20 4/23/21 4/21/22 4/26/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - 469 457 - - -
Net Cash position 1 365 - - 1,671 2,409 1,383
Leverage (Debt/EBITDA) - 5.727 x 6.598 x - - -
Free Cash Flow 1 -1,063 1,240 34.2 -2,117 2,230 -237
ROE (net income / shareholders' equity) 1.28% 3.11% 1.8% 13% 16.6% 3.06%
ROA (Net income/ Total Assets) 0.99% 0.92% 0.48% -0.18% 0.68% 1.38%
Assets 1 12,358 180,320 16,931 -360,419 108,902 7,695
Book Value Per Share 2 1.760 2.860 2.940 3.260 2.420 2.520
Cash Flow per Share 2 0.2300 0.0600 0.0800 1.080 1.460 0.8800
Capex 1 260 124 47.4 7.88 11.3 52.5
Capex / Sales 90.65% 39.8% 13.08% 3.18% 4.17% 9.77%
Announcement Date 4/27/18 4/24/19 4/28/20 4/23/21 4/21/22 4/26/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1358 Stock
  4. Financials PW Medtech Group Limited